Top Markets
Coin of the day
Medtronic plc Medtronic plc

Medtronic plc

2M6
Pozycja w akcjach #164
Medtronic plc develops, manufactures, and sells device-based medical therapies... Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Cena akcji
$88.89
Kapitalizacja rynkowa
$114.13B
Zmiana (1 dzień)
-0.93%
Zmiana (1 rok)
-2.08%
Kraj
IE
Handel Medtronic plc (2M6)

Kategoria

Marża operacyjna dla Medtronic plc (2M6)
Marża operacyjna na dzień March 2026 TTM: 17.86%
Według najnowszych raportów finansowych i ceny akcji Medtronic plc, bieżąca marża operacyjna (TTM) wynosi 17.86%. Na koniec 2024 wynosiła 15.89%.
Historia marży operacyjnej dla Medtronic plc od 2000 do 2026
Marża operacyjna na koniec każdego roku
Rok Marża operacyjna Zmień
2026 (TTM) 17.86% 0.56%
2025 17.76% 11.77%
2024 15.89% -9.51%
2023 17.56% -3.25%
2022 18.15% 21.89%
2021 14.89% -10.14%
2020 16.57% -19.21%
2019 20.51% -7.49%
2018 22.17% 22.35%
2017 18.12% -2.53%
2016 18.59% 0.00%
2015 18.59% -17.08%
2014 22.42% -15.49%
2013 26.53% -4.22%
2012 27.70% -1.04%
2011 27.99% -7.50%
2010 30.26% 27.52%
2009 23.73% -12.14%
2008 27.01% -11.15%
2007 30.40% -7.35%
2006 32.81% -4.20%
2005 34.25% -2.17%
2004 35.01% 1.13%
2003 34.62% 3.28%
2002 33.52% -0.92%
2001 33.83% 0.77%
2000 33.57% 0.00%
Marża operacyjna dla podobnych firm lub konkurentów
Firma Marża operacyjna Różnica w marży operacyjnej Kraj
18.16% -98.98%
US
22.44% -98.74%
US
17.86% -99.00%
IE
19.78% -98.89%
US
14.72% -99.18%
DE
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.